Sierra Oncology Announces Momelotinib Achieved Statistically Significant Benefit on Symptoms, Anemia and Splenic Size in the Pivotal MOMENTUM Study for Myelofibrosis —New Drug Application submission planned for second quarter of 2022— —Full data set to be presented at...
Sierra Oncology Announces Pricing of Upsized Public Offering of Securities SAN MATEO, Calif.–(BUSINESS WIRE)– Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company dedicated to delivering targeted therapies for rare cancers, today...
PDS Biotech Announces Preclinical Data for PDS0202 Universal Influenza VaccinePDS0202 (Infectimune™ + COBRA Influenza Antigens) neutralized multiple strains of the flu and provided effective protection against infection in preclinical studies FLORHAM PARK, N.J., Jan....
TigerConnect Secures Strategic Growth Investment from Vista Equity PartnersPartnership will expand TigerConnect’s ability to deliver software to support healthcare organizations and professionals in their mission of improving patient health outcomes SANTA MONICA,...
State of Minnesota Selects Truveris to Help Optimize its Pharmacy Benefits ProgramState to use Truveris’ proprietary truBid® technology for PBM procurement and ongoing oversight of all pharmacy claims. NEW YORK, JANUARY 12, 2022 – Truveris, the leader in pharmacy cost...
Recent Comments